99 related articles for article (PubMed ID: 27392656)
1. [Not Available].
Lassale C; Sibenaler C; Béhier JM; Plétan Y; Courcier S
Therapie; 2008; 63(5):345-57. PubMed ID: 27392656
[TBL] [Abstract][Full Text] [Related]
2. [France, an attractive country for international clinical research: 2008 survey assessed by Leem (French association of pharmaceutical companies)].
Lassale C; Sibenaler C; Béhier JM; Plétan Y; Courcier S;
Therapie; 2008; 63(5):345-57. PubMed ID: 19154705
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Courcier S; Sibenaler C; Couderc M; Trinquet F; Plétan Y; Lassale C; le Groupe de Travail Attractivité de la France du Leem
Therapie; 2006; 61(5):407-18. PubMed ID: 27392823
[TBL] [Abstract][Full Text] [Related]
4. [France, an attractive country for international clinical research: 2010 survey assessed by Leem (French association of pharmaceutical companies)].
Lassale C; Sibenaler C; Behier JM; Pletan Y; Courcier S
Therapie; 2011; 66(1):1-15. PubMed ID: 21466772
[TBL] [Abstract][Full Text] [Related]
5. [The attractive position of France in international clinical research: 2006 survey assessed by Leem (French pharmaceutical companies)].
Courcier S; Sibenaler C; Couderc M; Trinquet F; Plétan Y; Lassale C;
Therapie; 2006; 61(5):407-18. PubMed ID: 17243270
[TBL] [Abstract][Full Text] [Related]
6. [Attractiveness of France for international clinical trials in 2012: 6(th) survey assessed by Leem (French association of pharmaceutical companies)].
Lassale C; Sibenaler C; Béhier JM; Barthélémy P; Plétan Y; Courcier S
Therapie; 2013; 68(1):1-18. PubMed ID: 23484655
[TBL] [Abstract][Full Text] [Related]
7. [Attractiveness of France for international clinical research: 8th survey conducted by Leem (French association for pharmaceutical companies)].
Galaup A; Barthélémy P; Pouletty-Lefebvre B; Béhier JM; Zetlaoui J; Borel T
Therapie; 2018 Oct; 73(5):367-376. PubMed ID: 29753391
[TBL] [Abstract][Full Text] [Related]
8. [A survey on the position of France in international clinical research as assessed by pharmaceutical laboratories].
Courcier-Duplantier S; Bouhours P; Pinton P; Sibenaler C; Lassale C;
Therapie; 2004; 59(6):629-38. PubMed ID: 15789827
[TBL] [Abstract][Full Text] [Related]
9. [Difficulties with conducting clinical trials in France].
Zannad F; Plétan Y
Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
[TBL] [Abstract][Full Text] [Related]
10. France's competitiveness in global pharmaceutical research: The situation is improving.
d'Andon A; Galaup A; Fabron C; Detournay B; Borel T
Therapie; 2021; 76(6):549-557. PubMed ID: 34053732
[TBL] [Abstract][Full Text] [Related]
11. [Organisation of clinical research in France: the new missions of inter-regional delegations for clinical research].
Jaillon P
Bull Acad Natl Med; 2008 May; 192(5):929-37; discussion 937-9. PubMed ID: 19238783
[TBL] [Abstract][Full Text] [Related]
12. The conduct of clinical trials for medicinal products in europe in the light of the European clinical trials directive. Review of regulatory and practical aspects in the different countries.
Dubray C; Maillere P; Spriet A;
Therapie; 2007; 62(3):193-7, 199-202. PubMed ID: 17803885
[TBL] [Abstract][Full Text] [Related]
13. [Attractiveness of France for clinical trials: evaluation of laboratories and promoters].
d'Enfert J; Lassale C; Prod'homme P
Therapie; 2003; 58(3):283-9. PubMed ID: 14655322
[TBL] [Abstract][Full Text] [Related]
14. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
15. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
17. The hidden face of academic researches on classified highly pathogenic microorganisms.
Devaux CA
Infect Genet Evol; 2015 Jan; 29():26-34. PubMed ID: 25445654
[TBL] [Abstract][Full Text] [Related]
18. [An analysis of the pharmaceuticals market in Vietnam].
Simonet D
Sante; 2001; 11(3):155-60. PubMed ID: 11641078
[TBL] [Abstract][Full Text] [Related]
19. [The investment of pharmaceutical industry in hospital clinical research: an estimate for france in 2010].
Fagnani F
Therapie; 2012; 67(2):89-96. PubMed ID: 22850096
[TBL] [Abstract][Full Text] [Related]
20. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
